Feb 2 (Reuters) - MoonLake Immunotherapeutics: * MOONLAKE IMMUNOTHERAPEUTICS COMPLETES PATIENT ENROLLMENT AND RANDOMIZATION AHEAD OF SCHEDULE IN A PHASE 2 TRIAL OF THE NANOBODY® SONELOKIMAB IN
Feb 2 (Reuters) - ADC Therapeutics SA: * ADC THERAPEUTICS ANNOUNCES PRICING OF UNDERWRITTEN OFFERING BY A SELLING SHAREHOLDER * ADC THERAPEUTICS - PRICING OF UNDERWRITTEN OFFERING OF 12 MILLION COMMON
(Adds WHO comment) By Jennifer Rigby and Gabrielle Tétrault-Farber LONDON/GENEVA, Feb 1 (Reuters) - Governments may have to reserve drugs and vaccines for the World Health Organization to distribute
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * STOXX 600 flat * Euro zone manufacturing downturn eases * Husqvarna climbs on Q4 sales
By Jennifer Rigby and Gabrielle Tétrault-Farber LONDON/GENEVA, Feb 1 (Reuters) - Governments may have to reserve drugs and vaccines for the World Health Organization to distribute in poorer countries
Feb 1 (Reuters) - Dubai stock market closed higher on Wednesday, outperforming the Gulf region, while Qatari stocks retreated amid volatile energy prices. Dubai's benchmark index snapped its losing
Feb 1 (Reuters) - New Silkroutes: * PROPOSED DISPOSAL OF DENTAL CLINICS BY INDIRECT UNITS OF COMPANY * CO AND SHAREHOLDERS ENTERED INTO BUSINESS TRANSFER AGREEMENT WITH DENTAL HUB IN RELATION TO SALE
BASEL, Feb 1 (Reuters) - Swiss pharmaceutics maker Novartis said on Wednesday China remains a large growth opportunity despite a drop in its population, as the government spurs efforts to make
Feb 1 (Reuters) - ViroGates A/S: * APPOINTS JOSEPHINE BAUM JØRGENSEN AS ITS NEW CFO * JOSEPHINE BAUM JØRGENSEN WILL BE JOINING VIROGATES AS CO'S NEW CFO SUCCEEDING MARK DA SILVA * JOSEPHINE WILL JOIN
Feb 1 (Reuters) - Greenlight Biosciences Holdings PBC : * GREENLIGHT BIOSCIENCES RECEIVES APPROVAL TO INITIATE PHASE I/II CLINICAL TRIAL OF COVID-19 MRNA VACCINE CANDIDATE * GREENLIGHT BIOSCIENCES